Von Willebrand factor in high-purity factor VIII complex concentrates: chaperone protein or key to therapies? A meeting report.
Federici
A B
AB
Department of Internal Medicine and Medical Specialties, Angelo Bianchi Bonomi Hemophilia Thrombosis Center, IRCCS Foundation Maggiore Policlinico Hospital, Mangiagalli, Regina Elena and University of Milan, Milan, Italy. augusto.federici@unimi.it
Mannucci
P M
PM
Marco
P
P
D005169:Factor VIII / Q000276:immunology / Q000627:therapeutic use*; D006467:Hemophilia A / Q000276:immunology / Q000628:therapy; D006801:Humans; D007108:Immune Tolerance; D007518:Isoantibodies / Q000097:blood; D018832:Molecular Chaperones; D011292:Premedication; D014842:von Willebrand Diseases / Q000276:immunology / Q000628:therapy; D014841:von Willebrand Factor / Q000276:immunology / Q000627:therapeutic use*
D007518:Isoantibodies; D018832:Molecular Chaperones; D014841:von Willebrand Factor; D005169:Factor VIII